![Nature Biotechnology Podcast show](https://d3dthqtvwic6y7.cloudfront.net/podcast-covers/000/048/187/small/nature-biotechnology-podcast-nature-com-science-feeds.jpg)
Summary: Henri Termeer discusses his path to Genzyme, the approval of Ceredase and the drawn-out negotiations with eventual acquirer Sanofi.
Summary: Henri Termeer discusses his path to Genzyme, the approval of Ceredase and the drawn-out negotiations with eventual acquirer Sanofi.